Selective Reduction of Interchain Disulfides in Native Antibodies is an Underexplored Problem

Interchain disulfide conjugation chemistry has enabled the generation of homogeneous antibody-drug conjugates (ADCs) but this is mostly restricted to drug-to-antibody ratio (DAR) 4 and DAR 8 constructs when using native antibodies. A native IgG1 has four interchain disulfide bonds: two heavy-heavy (H-H) bonds in the hinge region, and two heavy-light (H-L) bonds. Selective reduction of one pair of bonds would allow greater control over drug loading and access to dual payload ADCs without the need for complex linker design or antibody engineering, however, this pursuit has received little attention. Herein, we highlight the research in this field to elucidate the differences between these bonds and how these subtleties have been exploited to enable selective disulfide reduction.

Authors

Publication Details

Journal
Apollo (University of Cambridge)
Published
2026-11-18
DOI
https://doi.org/10.17863/cam.137040
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Selective Reduction of Interchain Disulfides in Native Antibodies is an Underexplored Problem

Thomas Wharton, Jessica Iegre, David Spring
Apollo (University of Cambridge)
Monoclonal and Polyclonal Antibodies Research
article

Selective Reduction of Interchain Disulfides in Native Antibodies is an Underexplored Problem

Thomas Wharton, Jessica Iegre, David Spring
article en

Abstract

Interchain disulfide conjugation chemistry has enabled the generation of homogeneous antibody-drug conjugates (ADCs) but this is mostly restricted to drug-to-antibody ratio (DAR) 4 and DAR 8 constructs when using native antibodies. A native IgG1 has four interchain disulfide bonds: two heavy-heavy (H-H) bonds in the hinge region, and two heavy-light (H-L) bonds. Selective reduction of one pair of bonds would allow greater control over drug loading and access to dual payload ADCs without the need for complex linker design or antibody engineering, however, this pursuit has received little attention. Herein, we highlight the research in this field to elucidate the differences between these bonds and how these subtleties have been exploited to enable selective disulfide reduction.

Apollo (University of Cambridge)
Good health and well-being
Monoclonal and Polyclonal Antibodies Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon